Prostanoids in pediatric pulmonary hypertension: clinical response, time-to-effect, and dose–response

by Joseph B. Tella, Thomas J. Kulik, Julia E. McSweeney, Lynn A. Sleeper, Minmin Lu, Mary P. Mullen
Published 2020-12-01

Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertension

by D. Dunbar Ivy, Jeffrey A. Feinstein, Delphine Yung, Mary P. Mullen, Edward C. Kirkpatrick, Russel Hirsch, Eric D. Austin, Jeffrey Fineman, Uyen Truong, Derek Solum, C.Q. Deng, Rachel K. Hopper
Published 2019-07-01

A homozygous stop-gain variant in ARHGAP42 is associated with childhood interstitial lung disease, systemic hypertension, and immunological findings.

by Qifei Li, Michal Dibus, Alicia Casey, Christina S K Yee, Sara O Vargas, Shiyu Luo, Samantha M Rosen, Jill A Madden, Casie A Genetti, Jan Brabek, Catherine A Brownstein, Shideh Kazerounian, Benjamin A Raby, Klaus Schmitz-Abe, John C Kennedy, Martha P Fishman, Mary P Mullen, Joan M Taylor, Daniel Rosel, Pankaj B Agrawal
Published 2021-07-01